Brian Piper, Chief Financial Officer at Prelude Therapeutics Inc (PRLD), sold 16,267 shares at $33.53 ($557K) on 2021-05-25, disclosed to the SEC on 2021-05-27.
Open-market sale of $557k PRLD by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.53 | 3,110 | $104K | 18.7% |
| 2 | $33.53 | 3,110 | $104K | 18.7% |
| 3 | $34.11 | 3,088 | $105K | 18.9% |
| 4 | $34.11 | 3,088 | $105K | 18.9% |
| 5 | $35.45 | 1,736 | $62K | 11.1% |
| 6 | $35.45 | 1,736 |
| $62K |
| 11.1% |
| 7 | $36.09 | 399 | $14K | 2.6% |
| Total | $34.22 avg | 16,267 | $557K | 100% |